Entera Bio Ltd. (ENTX)

Entera Bio Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-8.89	-13.07	-12.19	-11.22	-10.8
Depreciation & Amortization	0.06	0.06	0.05	0.06	0.24
Share-Based Compensation	1.69	2.25	1.86	0.9	1.48
Other Operating Activities	-0.17	-1.74	1.21	-0.31	0.16
Operating Cash Flow	-7.31	-12.5	-9.06	-10.56	-8.92
Capital Expenditures	-0.02	-0.05	-0.02	-0.05	-0.04
Acquisitions	0	-0.06	0	0	0
Change in Investments	0	0	0	0	4
Other Investing Activities	-	-	-	-	-0.01
Investing Cash Flow	-0.02	-0.1	-0.02	-0.05	3.95
Share Issuance / Repurchase	6.62	0.01	25.38	4.05	12.77
Debt Issued / Paid	0	0	0	0	-0.11
Other Financing Activities	-0.58	-	-	-	-
Financing Cash Flow	6.04	0.01	25.38	4.05	12.65
Net Cash Flow	-1.29	-12.59	16.3	-6.56	7.68
Free Cash Flow	-7.33	-12.55	-9.08	-10.61	-8.96
Free Cash Flow Margin	-	-9362.69%	-1590.19%	-2906.85%	-3796.19%
Free Cash Flow Per Share	-0.25	-0.44	-0.35	-0.58	-0.74

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).